| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916008 | Nuclear Medicine and Biology | 2014 | 6 Pages |
Abstract
Favorable dosimetry estimates together with previously reported uPAR PET data fully support human testing of 64Cu-DOTA-AE105.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Morten Persson, Henrik H. El Ali, Tina Binderup, Andreas Pfeifer, Jacob Madsen, Palle Rasmussen, Andreas Kjaer,